CX3CR1 and cancer: However, altered chemokine axes cannot explain all defects in the recruitment of NK cells, as in some cancers CX3CL1 (the ligand for CX3CR1) expression is high but CD16+ NK cells are not present, despite expressing CX3CR1 (144).